Negativity begets longevity in T cells.
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
15 06 2023
15 06 2023
Historique:
medline:
16
6
2023
pubmed:
15
6
2023
entrez:
15
6
2023
Statut:
epublish
Résumé
Killer immunoglobulin-like receptors (KIRs) are polymorphic receptors for human leukocyte antigens (HLAs) that provide positive or negative signals controlling lymphocyte activation. Expression of inhibitory KIRs by CD8+ T cells affects their survival and function, which is linked to improved antiviral immunity and prevention of autoimmunity. In this issue of the JCI, Zhang, Yan, and co-authors demonstrate that increased numbers of functional inhibitory KIR-HLA pairs equating to greater negative regulation promoted longer lifespans of human T cells. This effect was independent of direct signals provided to KIR-expressing T cells and was instead driven by indirect mechanisms. Since the long-term maintenance of CD8+ T cells is critical for immune readiness against cancer and infection, this discovery has implications for immunotherapy and the preservation of immune function during aging.
Identifiants
pubmed: 37317967
pii: 171027
doi: 10.1172/JCI171027
pmc: PMC10266772
doi:
pii:
Substances chimiques
Antiviral Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR073228
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148080
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI176519
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM063483
Pays : United States
Commentaires et corrections
Type : CommentOn
Références
J Virol. 2008 Oct;82(19):9668-77
pubmed: 18579582
J Immunol. 2011 Mar 15;186(6):3304-8
pubmed: 21307295
Clin Cancer Res. 2022 Feb 1;28(3):468-478
pubmed: 34667025
Annu Rev Biochem. 2020 Jun 20;89:717-739
pubmed: 32569519
Science. 2022 Apr 15;376(6590):eabi9591
pubmed: 35258337
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1210-5
pubmed: 22167808
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2010-5
pubmed: 21233417
Sci Immunol. 2018 Nov 9;3(29):
pubmed: 30413420
J Clin Invest. 2023 Jun 15;133(12):
pubmed: 37071474
Immune Netw. 2023 Feb 20;23(1):e8
pubmed: 36911797
J Immunol. 2003 Apr 1;170(7):3572-6
pubmed: 12646619
Nature. 2011 Nov 20;481(7381):394-8
pubmed: 22101430
Nat Immunol. 2001 May;2(5):430-5
pubmed: 11323697
Aging Cell. 2021 Jun;20(6):e13372
pubmed: 34043881
Cytometry B Clin Cytom. 2021 Jul;100(4):467-475
pubmed: 32830898
Nat Commun. 2016 Feb 10;7:10554
pubmed: 26861112
Cancer Res. 2003 Nov 1;63(21):7475-82
pubmed: 14612548
Front Immunol. 2022 Sep 29;13:940577
pubmed: 36248873
J Exp Med. 2002 Feb 4;195(3):335-41
pubmed: 11828008
Eur J Immunol. 2003 Jun;33(6):1657-66
pubmed: 12778484